34 related articles for article (PubMed ID: 1604271)
1. Assessment of lead exposure risk in locksmiths.
Kondrashov V; McQuirter JL; Miller M; Rothenberg SJ
Int J Environ Res Public Health; 2005 Apr; 2(1):164-9. PubMed ID: 16705814
[TBL] [Abstract][Full Text] [Related]
2. Predictors of DMSA chelatable lead, tibial lead, and blood lead in 802 Korean lead workers.
Todd AC; Lee BK; Lee GS; Ahn KD; Moshier EL; Schwartz BS
Occup Environ Med; 2001 Feb; 58(2):73-80. PubMed ID: 11160984
[TBL] [Abstract][Full Text] [Related]
3. Male reproductive toxicity of lead in animals and humans. ASCLEPIOS Study Group.
Apostoli P; Kiss P; Porru S; Bonde JP; Vanhoorne M
Occup Environ Med; 1998 Jun; 55(6):364-74. PubMed ID: 9764095
[TBL] [Abstract][Full Text] [Related]
4. Bone lead as a new biologic marker of lead dose: recent findings and implications for public health.
Hu H
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):961-7. PubMed ID: 9703479
[TBL] [Abstract][Full Text] [Related]
5. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.
Schwartz BS; Lee BK; Stewart W; Sithisarankul P; Strickland PT; Ahn KD; Kelsey K
Occup Environ Med; 1997 Apr; 54(4):241-6. PubMed ID: 9166129
[TBL] [Abstract][Full Text] [Related]
6. In vivo X-ray fluorescence of lead in bone: review and current issues.
Todd AC; Chettle DR
Environ Health Perspect; 1994 Feb; 102(2):172-7. PubMed ID: 8033846
[TBL] [Abstract][Full Text] [Related]
7. Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.
Schwartz BS; McGrail MP; Stewart W; Pluth T
Occup Environ Med; 1994 Oct; 51(10):669-73. PubMed ID: 8000491
[TBL] [Abstract][Full Text] [Related]
8. Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: an epidemiological review.
Balbus-Kornfeld JM; Stewart W; Bolla KI; Schwartz BS
Occup Environ Med; 1995 Jan; 52(1):2-12. PubMed ID: 7697135
[TBL] [Abstract][Full Text] [Related]
9. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
Bradberry S; Vale A
Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
[TBL] [Abstract][Full Text] [Related]
10. Lead nephropathy, gout, and hypertension.
Batuman V
Am J Med Sci; 1993 Apr; 305(4):241-7. PubMed ID: 8475950
[TBL] [Abstract][Full Text] [Related]
11. Chelated lead and bone lead.
Tell I; Somervaille LJ; Nilsson U; Bensryd I; Schütz A; Chettle DR; Scott MC; Skerfving S
Scand J Work Environ Health; 1992 Apr; 18(2):113-9. PubMed ID: 1604271
[TBL] [Abstract][Full Text] [Related]
12. In vivo measurements of lead in bone in long-term exposed lead smelter workers.
Gerhardsson L; Attewell R; Chettle DR; Englyst V; Lundström NG; Nordberg GF; Nyhlin H; Scott MC; Todd AC
Arch Environ Health; 1993; 48(3):147-56. PubMed ID: 8333784
[TBL] [Abstract][Full Text] [Related]
13. Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man.
Hansen JP; Døssing M; Paulev PE
J Occup Med; 1981 Jan; 23(1):39-43. PubMed ID: 6782204
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism.
Brito JA; McNeill FE; Stronach I; Webber CE; Wells S; Richard N; Chettle DR
J Environ Monit; 2001 Aug; 3(4):343-51. PubMed ID: 11523432
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.
Hu H; Pepper L; Goldman R
Am J Ind Med; 1991; 20(6):723-35. PubMed ID: 1805610
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
